| # | Drug | Count |
|---|---|---|
| 0 | GABAPENTIN | 8 |
| 1 | OMEPRAZOLE MAGNESIUM | 8 |
| 2 | OMEPRAZOLE | 7 |
| 3 | ADALIMUMAB | 6 |
| 4 | CEFIXIME | 6 |
| 5 | FLUTICASONE PROPIONATE | 6 |
| 6 | ADALIMUMAB-ATTO | 5 |
| 7 | ALPRAZOLAM | 4 |
| 8 | DEXAMETHASONE | 4 |
| 9 | DEXAMETHASONE 1.5 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-ATTO | 5 | 0.0031 |
| 1 | CEFIXIME | 6 | 0.0020 |
| 2 | TRABECTEDIN | 1 | 0.0004 |
| 3 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 4 | REMDESIVIR | 2 | 0.0002 |
| 5 | BICALUTAMIDE | 2 | 0.0001 |
| 6 | LUMACAFTOR AND IVACAFTOR | 1 | 0.0001 |
| 7 | ITRACONAZOLE | 1 | 0.0001 |
| 8 | ABIRATERONE ACETATE | 3 | 0.0001 |
| 9 | VALGANCICLOVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Catecholamine [EPC] | 1 | 0.0000 |
| 6 | Proton Pump Inhibitor [EPC] | 7 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 1 | 0.0000 |